CP
CPHL-CNOV.KAR Citi Pharma Ltd
58.99 PKR
Close of Oct 29, 2026 - Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is CPHL-CNOV.KAR undervalued?
Graham numberThe Graham number of Citi Pharma Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Citi Pharma Ltd fundamental analysis
No fundamental analysis for Citi Pharma Ltd yet.
Citi Pharma Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of Citi Pharma Ltd are not available yet.
Citi Pharma Ltd dividends
Citi Pharma Ltd has not paid dividends in the last 1 fiscal years.
Who owns Citi Pharma Ltd
Ownership data of Citi Pharma Ltd is not available yet.
Citi Pharma Ltd company profile
- Company name
- Citi Pharma Ltd
- Ticker
- CPHL-CNOV.KAR
- Exchange
- Karachi Stock Exchange
- Sector
- -
- Industry
- -
- Address
- Website
- -